Roberto Bitton
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Toxin Mechanisms and Immunotoxins
- Galectins and Cancer Biology
-
- Glycosylation and Glycoproteins Research
- Heat shock proteins research
Papers in
-
- Immunotherapy and Immune Responses 5
-
- Glycosylation and Glycoproteins Research 3
- Heat shock proteins research 1
- Co-authors
- Len Neckers (1 shared paper)Edward G. Mimnaugh (1 shared paper)James D. Moyer (1 shared paper)Luke Whitesell (1 shared paper)Rodney C. Schnur (1 shared paper)Jane B. Trepel (1 shared paper)Christine Chavany (1 shared paper)Ana María Vázquez (2 shared papers)
- Journals
- Journal of Immunotherapy (2 papers)The Journal of Immunology (1 paper)Drug Safety (1 paper)Journal of Clinical Oncology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesArgentinaCuba
In The Last Decade
Roberto Bitton
9 papers receiving 560 citations
Peers
Comparison fields: 5 of 68
- Immunology 220
- Molecular Biology 425
- Radiology, Nuclear Medicine and Imaging 95
- Cell Biology 68
- Oncology 92
Countries citing papers authored by Roberto Bitton
This map shows the geographic impact of Roberto Bitton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Bitton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Bitton more than expected).
Fields of papers citing papers by Roberto Bitton
This network shows the impact of papers produced by Roberto Bitton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Bitton. The network helps show where Roberto Bitton may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Bitton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 238 | |
| 2 | 2002 | 100 | |
| 3 | 2002 | 58 | |
| 4 | 2006 | 52 | |
| 5 | 1996 | 36 | |
| 6 | 2004 | 35 | |
| 7 | 1995 | 31 | |
| 8 | 1995 | 20 | |
| 9 | Cancer vaccines: a critical review on clinical impact. | 2004 | 12 |
| 10 | LEUCEMIA MIELOIDE CRONICA MECANISMOS GENETICOS DE RESISTENCIA AL IMATINIB | 2007 | 0 |
About Roberto Bitton
Roberto Bitton is a scholar working on Immunology, Molecular Biology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 10 papers that have together received 582 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer Research and Treatments (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Heat shock proteins research (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Trypanosoma species research and implications (1 paper). The work is most often cited by research in Immunology (220 citations), Molecular Biology (425 citations), Radiology, Nuclear Medicine and Imaging (95 citations), Cell Biology (68 citations) and Oncology (92 citations). Roberto Bitton has collaborated with scholars based in United States, Argentina and Cuba. Frequent co-authors include Len Neckers, Edward G. Mimnaugh, James D. Moyer, Luke Whitesell, Rodney C. Schnur, Jane B. Trepel, Christine Chavany, Ana María Vázquez, Marcelo D. Guthmann and Leonardo Fainboim. Their work appears in journals such as Journal of Immunotherapy, The Journal of Immunology, Drug Safety, Journal of Clinical Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.